Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000082 |
Acetaminophen |
Acetaminophen results in increased expression of CDH5 mRNA | increases expression | 12540782
|
D000082 |
Acetaminophen |
O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [Acetaminophen results in increased expression of CDH5 mRNA] | decreases reaction|increases expression | 12540782
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of CDH5 mRNA | increases expression | 15238619
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in decreased expression of CDH5 mRNA | affects cotreatment|decreases expression | 17404688
|
D005665 |
Furosemide |
Furosemide results in decreased expression of CDH5 mRNA | decreases expression | 16526316
|
C091888 |
monoisoamyl-2,3-dimercaptosuccinate |
monoisoamyl-2,3-dimercaptosuccinate affects the expression of CDH5 mRNA | affects expression | 19615344
|
C091888 |
monoisoamyl-2,3-dimercaptosuccinate |
[sodium arsenite co-treated with monoisoamyl-2,3-dimercaptosuccinate] results in increased expression of CDH5 mRNA | affects cotreatment|increases expression | 19615344
|
D037742 |
Nanotubes, Carbon |
Nanotubes, Carbon results in decreased expression of CDH5 mRNA | decreases expression | 15585362
|
C107010 |
O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate |
O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [Acetaminophen results in increased expression of CDH5 mRNA] | decreases reaction|increases expression | 12540782
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in decreased expression of CDH5 mRNA | affects cotreatment|decreases expression | 17404688
|
C017947 |
sodium arsenite |
[sodium arsenite co-treated with monoisoamyl-2,3-dimercaptosuccinate] results in increased expression of CDH5 mRNA | affects cotreatment|increases expression | 19615344
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of CDH5 mRNA | decreases expression | 19615344
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of CDH5 mRNA | increases expression | 17879257
|
C025643 |
vinclozolin |
vinclozolin affects the expression of CDH5 mRNA | affects expression | 19015723
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.13 | 11473722 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.96 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.17 | 16712894 17306315 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.11 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.78 | 19015723 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
4.10 | 15238619 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.41 | 18445737 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.60 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.47 | 15665606 15380490 15845082 |
MESH:D001943 |
Breast Neoplasms |
marker/mechanism |
|
| 18507500 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
1.92 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.92 | 17018787 17289903 18497071 16675129 19861407 12948864 17261762 14630087 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
1.92 | 17614352 15562024 16175315 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.70 | 16111702 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
4.67 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
4.67 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
4.67 | 16507464 17306315 15276417 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
2.42 | 18572023 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.67 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
7.13 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
7.13 | 19524636 20056578 |
MESH:D015179 |
Colorectal Neoplasms |
marker/mechanism |
|
| 18507500 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.54 | 14966744 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.56 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.71 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
4.50 | 16227642 18713872 14725611 12705907 16781746 11743745 16109766 18071297 19416960 17906064 16081117 11739529 10915739 12540782 11834606 15619225 11287661 19923254 19739265 14550746 11461765 2444490 19085960 12958197 15968718 11421492 16177239 16393943 19164858 10774834 10663392 16485898 19370779 12594235 19420014 11529661 17522070 14986274 12153990 17562736 12392966 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate |
4.50 | 12540782 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.36 | 19426721 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.57 | 18367378 |
MESH:D004417 |
Dyspnea |
|
Furosemide |
5.21 | 16935035 |
MESH:D004487 |
Edema |
|
Furosemide |
4.17 | 11834646 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.98 | 17692515 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
3.09 | 19148513 18566989 11473722 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
3.93 | 16134523 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
3.41 | 19004024 19551842 18296743 17967931 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
3.74 | 18296743 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.94 | 16983495 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
5.17 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.57 | 16417039 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.92 | 16452187 |
MESH:D034381 |
Hearing Loss |
|
Furosemide |
4.98 | 17868369 |
MESH:D006333 |
Heart Failure |
|
Furosemide |
4.16 | 16011733 16845234 12660669 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.30 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.30 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
4.02 | 17088409 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.84 | 16870215 |
MESH:D006934 |
Hypercalcemia |
|
Furosemide |
5.25 | 17652376 |
MESH:D053565 |
Hypercalciuria |
|
Furosemide |
5.89 | 17652376 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.76 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.80 | 21332399 |
MESH:D006962 |
Hyperparathyroidism, Secondary |
|
Furosemide |
6.14 | 15086907 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Furosemide |
5.50 | 16612254 |
MESH:C537153 |
Hypomagnesemia primary |
|
Furosemide |
5.89 | 11041285 |
MESH:D007019 |
Hypoproteinemia |
|
Furosemide |
6.14 | 16096441 |
MESH:D007022 |
Hypotension |
|
Furosemide |
4.80 | 11041285 |
MESH:D007024 |
Hypotension, Orthostatic |
|
Furosemide |
5.68 | 15811171 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.62 | 15869954 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
7.22 | 15346721 12646999 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
7.22 | 16467254 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
5.46 | 20412841 |
MESH:D007249 |
Inflammation |
|
Progesterone |
5.46 | 15869954 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
7.73 | 11836018 18457598 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.73 | 16393666 16627594 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
15.26 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
15.26 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Furosemide |
15.26 | 11041285 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
15.26 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
3.12 | 15610895 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.97 | 16417039 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
2.96 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
1.68 | 14659978 14716833 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.66 | 19014921 12587719 19460945 11587558 16611625 19784758 12969438 16610002 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.40 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
2.42 | 15276417 16712894 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.28 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
1.89 | 17306315 15276417 17077188 19931552 16712894 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
6.41 | 17203775 11807958 16891317 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
6.41 | 17203775 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.75 | 19453300 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.05 | 16487513 19082730 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.78 | 19513568 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.41 | 16810080 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
2.57 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.88 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.97 | 17289903 |
MESH:D009397 |
Nephrocalcinosis |
|
Furosemide |
6.14 | 15086907 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
3.85 | 11399458 16427766 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.25 | 12854658 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
3.01 | 18514411 |
MESH:D053206 |
Nocturnal Enuresis |
|
Furosemide |
6.14 | 17945291 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
2.32 | 21332399 20132043 18674790 17217161 16723640 11836018 18457598 20518802 19632207 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
8.18 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
8.18 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
8.18 | 17306315 15276417 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.53 | 16870215 |
MESH:D011141 |
Polyuria |
|
Furosemide |
5.89 | 17945291 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
4.13 | 18042343 19015723 18220299 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
5.17 | 18220299 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.06 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.19 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.19 | 16039940 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
5.17 | 18629315 |
MESH:D015427 |
Reperfusion Injury |
|
Furosemide |
3.98 | 16526316 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Furosemide |
4.80 | 15912074 12394941 16096441 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.91 | 18045962 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
2.77 | 19524636 18572023 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.52 | 15862959 16503802 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.93 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Furosemide |
2.86 | 17052386 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.95 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
2.56 | 16712894 16452187 17306315 11723127 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.16 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.93 | 11813266 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.66 | 17056641 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.89 | 16723640 |